Provided is a crystal of a tricyclic pyrazolopyrimidine compound that inhibits the action of Hsp90. The present invention provides a crystal of 2 {4 amino 2 [(3 chloro 4 methoxy 5 methylpyridine 2 yl)methyl] 2 7 dihydro 6 thia 1 2 3 5 tetraazabenzo[cd]azulene 8 yl} N methylacetamide that inhibits the activity of Hsp90 ATPase and has antitumor activity and a medicine anticancer agent and the like containing the same.